-
Lithium Enhances Osteogenesis via Exosomal Wnt10a and β-Cate
2026-06-29
This study reveals how lithium treatment boosts bone regeneration by promoting exosomal Wnt10a secretion from bone mesenchymal stem cells (BMSCs), driving β-catenin signaling through Rab11a-mediated trafficking. The findings clarify lithium’s mechanistic role in osteogenesis and highlight its translational promise for engineering stem cell-based therapies in bone repair.
-
ddhCTP: Applied Workflows for RNA Virus Replication Inhibiti
2026-06-29
Harness the unique chain-terminating power of ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) to dissect viral RNA synthesis and develop next-generation antiviral screens. This guide translates recent reference breakthroughs into actionable protocols, advanced troubleshooting, and strategic insights for optimizing ddhCTP-driven assays in antiviral research.
-
Overcoming BRAFV600E Melanoma Resistance via EZH2, AKT1, and
2026-06-28
This study demonstrates that resistance to both eIF4F complex and BRAF inhibitors in BRAFV600E mutant melanoma cells can be overcome by combinational inhibition of EZH2, AKT1, and eIF4F. By dissecting the compensatory signaling mechanisms, the research offers a mechanistic blueprint for rational combination therapies in melanoma and highlights new strategies for tackling therapeutic resistance.
-
APEX2 Regulates TERT Expression in Human Stem Cells and Canc
2026-06-27
This study identifies APEX2 as an essential regulator of TERT gene expression in human embryonic stem cells and melanoma cells, independent from the related enzyme APEX1. By mapping APEX2 binding sites and analyzing gene expression after APEX2 knockdown, the research reveals a novel link between DNA repair at repetitive elements and telomerase regulation, with implications for stem cell biology and cancer therapeutics.
-
Chlorin e6 Photosensitizer: Workflows & Innovations in PDT
2026-06-26
Chlorin e6 (Ce6) is redefining photodynamic therapy with robust anticancer and antibacterial applications, offering exceptional ROS-driven cytotoxicity and biomaterial compatibility. Explore protocol-driven insights, advanced applications, and troubleshooting strategies for maximizing Ce6’s translational impact in research.
-
Vorinostat (SAHA): Epigenetic Modulation Workflows in Oncolo
2026-06-26
Vorinostat (SAHA, MK0683) is a precision histone deacetylase inhibitor that enables robust, reproducible epigenetic modulation in cancer biology research. This guide details optimized workflows, troubleshooting strategies, and new insights for leveraging Vorinostat in apoptosis assays and advanced oncology models.
-
Scenario-Driven Solutions with EdU Flow Cytometry Assay Kits
2026-06-25
This in-depth, scenario-driven article addresses real laboratory challenges in cell proliferation and DNA synthesis analysis, demonstrating how EdU Flow Cytometry Assay Kits (Cy3) (SKU K1077) enable reproducible, high-sensitivity flow cytometry workflows. Grounded in recent literature and practical experience, the discussion spans protocol optimization, data interpretation, and vendor selection, equipping biomedical researchers with actionable strategies for reliable S-phase quantification.
-
iPSC-Derived Organoids Advance Multitissue HEV Infection Mod
2026-06-25
This study pioneers the use of iPSC-induced liver, intestinal, and brain organoids to sustain the full life cycle of hepatitis E virus (HEV) genotypes 1, 3, and 4. The resulting platform reveals new mechanisms of viral pathogenesis across multiple tissues and offers a robust surrogate for antiviral drug development, addressing critical gaps in HEV research.
-
Deoxynivalenol Hepatotoxicity: Mitophagy Overactivation & Nr
2026-06-24
This study uncovers how deoxynivalenol (DON), a common food and feed contaminant, induces liver injury by overactivating PINK1/Parkin-mediated mitophagy and concurrently suppressing the p62-Keap1-Nrf2 cytoprotective pathway. These findings clarify DON’s molecular toxicity mechanism and highlight new experimental targets for mitigating mycotoxin-induced hepatic damage.
-
Berberrubine Inhibits Thrombosis by Targeting Vitamin K Cycl
2026-06-23
This study demonstrates that berberrubine, a metabolite of berberine, inhibits thrombus formation in mice by modulating the vitamin K catalytic cycle. Using integrated metabolomics and molecular docking, the research uncovers berberrubine’s mechanism of action and its potential as a safer antithrombotic agent, addressing limitations of current therapies.
-
Prednisolone in Glucocorticoid Signaling: Applied Research W
2026-06-23
Prednisolone, a synthetic glucocorticoid, is essential for precise modulation of inflammation and immunology research. This article delivers advanced workflows, troubleshooting strategies, and actionable insights—bridging targeted protein degradation innovations with reproducible glucocorticoid signaling assays.
-
High-Throughput In Vitro Model for BBB Permeability Predicti
2026-06-22
This study introduces a robust, high-throughput in vitro model that integrates LLC-PK1-MOCK/MDR1 cells and lysosomal trapping correction for accurate blood-brain barrier (BBB) permeability prediction. The model enables reliable early-stage screening of central nervous system (CNS) drug candidates, improving translational success and reducing reliance on animal studies.
-
AG-120 (Ivosidenib): Advanced Targeting of Metabolic Vulnera
2026-06-22
Explore how AG-120 (Ivosidenib) enables precise disruption of mutant IDH1-driven metabolic rewiring in AML. This in-depth analysis reveals new research avenues beyond 2-hydroxyglutarate reduction, grounded in recent mechanistic discoveries.
-
Ellagic Acid: Precision CK2 Inhibition in Cancer Biology Res
2026-06-21
Ellagic acid, a selective ATP-competitive CK2 inhibitor, empowers researchers to dissect apoptosis and oxidative stress in cancer models with exceptional specificity. This article provides actionable protocols, troubleshooting guidance, and translational insights from AI-driven senolytic discovery studies. Discover how APExBIO's ellagic acid is reshaping experimental workflows for advanced cancer biology research.
-
Practical Use of Annexin V-FITC/7-AAD Apoptosis Kit (K1139)
2026-06-20
The Annexin V-FITC/7-AAD Apoptosis Kit provides a sensitive, dual-parameter method for distinguishing apoptotic and necrotic cells in cell viability and cytotoxicity assays. It is most appropriate for rapid, fluorescence-based cell death analysis by flow cytometry or microscopy, but should not be used for mechanistic studies beyond phosphatidylserine exposure without additional assays.